摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine | 254879-86-2

中文名称
——
中文别名
——
英文名称
3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine
英文别名
N3,N6-di(1H-tetrazol-5-yl)-1,2,4,5-tetrazine-3,6-diamine;3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-s-tetrazine;N3,N6-di(1N-tetrazol-5-yl)-1,2,4,5-tetrazine-2,6-diamine;N3,N6-di(1H-tetrazole-5-yl)-1,2,4,5-tetrazine-3,6-diamine;N~3~,N~6~-Bis(2H-tetrazol-5-yl)-1,2,4,5-tetrazine-3,6-diamine;3-N,6-N-bis(2H-tetrazol-5-yl)-1,2,4,5-tetrazine-3,6-diamine
3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine化学式
CAS
254879-86-2
化学式
C4H4N14
mdl
——
分子量
248.17
InChiKey
UDJIUFKEBRBYGX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    320 °C
  • 沸点:
    736.6±43.0 °C(Predicted)
  • 密度:
    2.247±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.9
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    185
  • 氢给体数:
    4
  • 氢受体数:
    12

反应信息

  • 作为反应物:
    描述:
    3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine 作用下, 以 二甲基亚砜 为溶剂, 以95%的产率得到di-hydrazinium salt of 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine
    参考文献:
    名称:
    3,6BIS(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine or salt thereof
    摘要:
    提供了化合物3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪及其盐,以及包括氧化剂、粘合剂和3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪或其盐的推进剂组合物。
    公开号:
    US06657059B2
  • 作为产物:
    描述:
    5-氨基四氮唑3,6-二(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪环丁砜 为溶剂, 反应 25.0h, 以61%的产率得到3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine
    参考文献:
    名称:
    BTATz初始分解步骤的拟质子转移机制
    摘要:
    N3,N6-双(1 H-四唑-5-基)-1,2,4,5-四嗪-3,6-二胺,BTATz气相分解机理的第一步,阴离子和动力学同位素效应在这些过程中使用组合多级质谱(MS / MS)和计算技术进行了研究。鉴定了两个主要的断裂过程,氮分子的能动损失和acid酸的负电子损失。计算支持的一次同位素效应的观察表明,作为速率确定步骤,四唑环中氮分子的损失涉及质子迁移到叔唑环中或在叔唑环中。an酸的片段化是通过不对称的后周环反应发生的。计算表明这些机制与中性BTATz的相关性。我们的发现可能有助于理解这些富含氮的高能材料中的分解途径,并允许调整其反应性和分解途径以更好地控制性能。
    DOI:
    10.1021/acs.jpca.7b12217
点击查看最新优质反应信息

文献信息

  • 테트라진 기반 추진제용 아졸계 이온성 물질 및 이의 제조 방법
    申请人:AGENCY FOR DEFENSE DEVELOPMENT 국방과학연구소(319980058262) BRN ▼314-83-03869
    公开号:KR20210094851A
    公开(公告)日:2021-07-30
    본 발명은 테트라진 기반의 추진제용 아졸계 이온성 물질 및 이의 제조방법에 관한 것으로, 상세하게는 테트리진을 기반으로 1종 또는 2종의 아졸계 양이온이 서로 연결된 형태의 테트라진 기반의 아졸계 양이온을 포함하여 높은 둔감성을 가지는 것을 특징으로 하는 아졸계 이온성 물질이며, 테트라진 기반의 아졸계 양이온에서 아졸계 고리의 치환기를 나이트로화하거나, 본 발명의 테트라진 기반 추진제용 아졸계 이온성 물질의 음이온을 할로겐 이온을 포함한 다양한 음이온들로 치환을 통해 연소 속도를 조절하여 높은 폭발 열과 반응 특성을 지니는 테트라진 기반의 추진제용 아졸계 이온성 물질 및 이의 제조방법에 관한 것이다.
    本发明涉及以四氮唑为基础的推进剂用偶氮类离子性物质及其制备方法,具体包括以四氮唑为基础,包含一种或两种偶氮类阳离子相互连接的形式的四氮唑基偶氮类阳离子,具有较高的不敏感性的偶氮类离子性物质,其中通过将四氮唑基偶氮类阳离子中偶氮环的取代基硝化,或者通过用含卤离子的各种阴离子替换来调节燃烧速度,具有高爆热和反应特性的基于四氮唑的推进剂用偶氮类离子性物质及其制备方法。
  • The nitration pattern of energetic 3,6-diamino-1,2,4,5-tetrazine derivatives containing azole functional groups
    作者:A. Aizikovich、A. Shlomovich、A. Cohen、M. Gozin
    DOI:10.1039/c5dt01641j
    日期:——
    6-diamine derivative 20 in a moderate yield. Structures and properties of 15 (in the form of its perchlorate salt, 16) and 20 were measured by FTIR, multinuclear NMR, MS, DSC and X-ray crystallography. It is important to note that compound 20 exhibits exothermic decomposition at 302 °C (DSC) and >353 N (sensitivity to friction), making it a highly-promising thermally-insensitive energetic material for further
    设计有前途的新的高能材料的成功策略之一是将燃料和氧化剂部分都结合到同一分子中。因此,近年来,作为具有更平衡的氧含量的化合物的各种硝基唑衍生物的合成已经变得非常流行。在这项工作的框架内,我们研究了N 3,N 6-双(1 H-四唑-5-基)-1,2,4,5-四嗪-3,6-二胺(BTATz; 5)和其烷基化衍生物N 3,N 6-双(2-甲基-2 H-四唑-5-基)-1,2,4,5-四嗪-3,6-二胺12,使用15用N标记的硝化剂,并通过15 N NMR监测和分析这些反应的产物。可以看出,两种化合物的硝化仅在环外(“桥联”)仲胺基团上进行。可能的四硝基衍生物异构体N,N '-(1,2,4,5-四嗪-3,6-二基)双(N-(1-硝基-1 H-四唑-5-基)-硝酰胺)6和N,N ′-(1,2,4,5-四嗪-3,6-二基)双(N-(2-硝基-2 H-四唑-5-基)硝酰胺)7,两者的OB = 0 %和979​​0和9903
  • 3,6BIS(1H-1,2,3,4-TETRAZOL-5-YLAMINO)-1,2,4,5-TETRAZINE OR SALT THEREOF
    申请人:——
    公开号:US20030168140A1
    公开(公告)日:2003-09-11
    The compound 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine and its salts are provided together with a propellant composition including an oxidizer, a binder and 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine or its salts.
    本发明提供了化合物3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四唑及其盐,以及包括氧化剂、粘合剂和3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四唑或其盐的推进剂组合物。
  • Propellant containing 3;6-BIS(1H-1,2,3,4-Tetrazol-5-ylamino)-1,2,4,5-tetrazine or salts thereof
    申请人:The Regents of the University of California
    公开号:US06458227B1
    公开(公告)日:2002-10-01
    The compound 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine and its salts are provided together with a propellant composition including an oxidizer, a binder and 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine or its salts.
    提供化合物3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四唑及其盐,以及包括氧化剂、粘合剂和3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四唑或其盐的推进剂组合物。
  • 3,6-Bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine–based energetic strontium(II) complexes: synthesis, crystal structure, and thermal properties
    作者:Xian-Bo Zhang、Ying-Hui Ren、Wen Li、Feng-Qi Zhao、Jian-Hua Yi、Bo-Zhou Wang、Ji-Rong Song
    DOI:10.1080/00958972.2013.796040
    日期:2013.6.1
    Two energetic strontium(II) complexes with nitrogen-rich 3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)-1,2,4,5-tetrazine (BTATz) were synthesized. The metal complexes were characterized by IR, elemental analysis, and single-crystal X-ray diffraction. DSC and TG-DTG were used to study the thermal behavior, non-isothermal decomposition reaction kinetics, self-accelerating decomposition temperature (T-SADT), thermal ignition temperature (T-TIT), critical temperature of thermal explosion (T-b), and the adiabatic time-to-explosion (t(TIad)). The data indicate competitive energetic materials.
查看更多

同类化合物

酸四嗪 甲四嗪-氨基叔丁酯 四嗪-氨基叔丁酯 嘧啶并[4,5-e]-1,2,3,4-四嗪 二甲基-1,2,4,5-四嗪 二氯均四嗪 METHYLTETRAZINE-ACID,甲基四嗪-羧基 6-苯基-1,2,4,5-四嗪-3-胺 6-乙基-1,2,4,5-四嗪-3-胺 6-丁基氨基-3-(3,5-二甲基吡唑-1-基)四嗪 6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-胺 3,6-二苯基-1,2,4,5-四嗪 3,6-二氨基-1,2-二氢-1,2,4,5-四嗪盐酸盐 3,6-二-4-吡啶基-1,2,4,5-四嗪 3,6-二-2-吡啶基-1,2,4,5-四嗪 3,6-二(噻吩-2-基)-1,2,4,5-四嗪 3,6-二(3-吡啶基)-1,2,4,5-四氮杂苯 3,6-二(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪 1-[6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-基]-2-(丙-2-亚基)肼 1,2-二氢-1,2,4,5-四嗪-3,6-二酮 1,2,4,5]四嗪-3,6-二羧酸 1,2,4,5-四嗪-3-胺 1,2,4,5-四嗪-3,6-二羧酸二甲酯 1,2,4,5-四嗪 (9CI)-吡咯并[2,1-d]-1,2,3,5-四嗪 (6-肼基-1,2,4,5-四嗪-3-基)肼 3-(3,5-Dimethyl-1-pyrazolyl)-6-(2-trifluoroacetylhydrazino)-1,2,4,5-tetrazine 3-cyclohexyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-ethyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 6-pentyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-benzyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-methyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine N'-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl)propionohydrazide 3-(2-ethylidenehydrazinyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine (1,2,4,5-tetrazine-3,6-diyl)dimethanol 3-amino-6-chloro-1,2,4,5-tetrazine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methyl-1,2,4,5-tetrazin-3-amine N-(tert-butyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-amine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-(prop-2-en-1-yl)-1,2,4,5-tetrazin-3-amine 3-(2-pyrimidyl)-6-(2-hydroxy)ethyl-1,2,4,5-tetrazine 3-isopropyl-6-phenyl-1,2,4,5-tetrazine 6-butylamino-3-chlorotetrazine 3,6-di(1H-pyrazol-4-yl)-1,2,4,5-tetrazine N-(1H-tetrazol-5-yl)-1,2,4,5-tetrazin-3-amine 3-(3,5-dimethylpyrazolyl)-6-[tris(hydroxylmethyl)aminomethane]-1,2,4,5-tetrazine 2-([1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-ylamino)-2-(hydroxymethyl)propane-1,3-diol 6-amino-1,2,4-triazolo<4,3-b><1,2,4,5>tetrazine N-phenethyl-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-amine 2,5-dioxopyrrolidin-1-yl 2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)acetate furazano-1,2,3,4-tetrazine 1,3-dioxide